Commission on Cancer's Quality of Care Measures
UC San Diego Health's cancer program is accredited by the
Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.
The data presented below is included in the CoC's quality-of-care measures for breast cancer, and are for diagnosis year 2017, the most recent year for which data is available. (Data is provided by the National Cancer Database.)
The purpose of the data is to compare the care of breast cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below measures. For more information about quality and safety measures, see
Quality Care.
Combination chemotherapy
considered within four months of diagnosis
(when appropriate) | 94.2%
| 89.8% | 91.1% | 92.8% | 93.5% |
Administration of hormone therapy considered within one year of diagnosis
(when appropriate) | 93.0%
| 88.4% | 90.2% | 91.7% | 92.0%
|
Radiation therapy
administered within one year of diagnosis for women receiving breast conservation surgery
(when appropriate) | 95.7%
| 88.0% | 89.5% | 90.4% | 91.1% |